Fu, Y.; Saraswat, A.; Wei, Z.; Agrawal, M.Y.; Dukhande, V.V.; Reznik, S.E.; Patel, K.
Development of Dual ARV-825 and Nintedanib-Loaded PEGylated Nano-Liposomes for Synergistic Efficacy in Vemurafnib-Resistant Melanoma. Pharmaceutics 2021, 13, 1005.
https://doi.org/10.3390/pharmaceutics13071005
AMA Style
Fu Y, Saraswat A, Wei Z, Agrawal MY, Dukhande VV, Reznik SE, Patel K.
Development of Dual ARV-825 and Nintedanib-Loaded PEGylated Nano-Liposomes for Synergistic Efficacy in Vemurafnib-Resistant Melanoma. Pharmaceutics. 2021; 13(7):1005.
https://doi.org/10.3390/pharmaceutics13071005
Chicago/Turabian Style
Fu, Yige, Aishwarya Saraswat, Zenghui Wei, Manas Yogendra Agrawal, Vikas V. Dukhande, Sandra E. Reznik, and Ketan Patel.
2021. "Development of Dual ARV-825 and Nintedanib-Loaded PEGylated Nano-Liposomes for Synergistic Efficacy in Vemurafnib-Resistant Melanoma" Pharmaceutics 13, no. 7: 1005.
https://doi.org/10.3390/pharmaceutics13071005
APA Style
Fu, Y., Saraswat, A., Wei, Z., Agrawal, M. Y., Dukhande, V. V., Reznik, S. E., & Patel, K.
(2021). Development of Dual ARV-825 and Nintedanib-Loaded PEGylated Nano-Liposomes for Synergistic Efficacy in Vemurafnib-Resistant Melanoma. Pharmaceutics, 13(7), 1005.
https://doi.org/10.3390/pharmaceutics13071005